Mackenzie Financial Corp Codexis, Inc. Transaction History

Mackenzie Financial Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 24, 2023	SELL	$3.81 - $6.76 $260,832 - $462,789	-68,460 Reduced 80.89%	16,171 $66,000
Q4 2022 Feb 14, 2023	BUY	$4.26 - $6.84 $360,528 - $578,876	84,631 New	84,631 $394,000
Q2 2019 Aug 14, 2019	SELL	$17.0 - $21.88 $224,400 - $288,816	-13,200 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$15.53 - $22.15 $204,996 - $292,380	13,200 New	13,200 $271,000

144

60.6M

68.5K

20.1K

Ticker CDXS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,494,100
Market Cap $274M
Description
Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Mackenzie Financial Corp with notifications on news.